On this page
FHL1
four and a half LIM domains 1
FHL1 encodes a muscle-specific protein essential for sarcomere assembly and muscle cell structure, with pathogenic variants causing a spectrum of X-linked muscular dystrophies. The FHL1 gene provides instructions for producing protein isoforms that play crucial roles in skeletal and cardiac muscle function.
FHL1 is located on the long (q) arm of chromosome X, at band Xq26.3. Arm ratio per GRCh38 - banding schematic.
Explore chromosome X in the library →Available at Jeen Health
Clinical tests that include this
Overview
FHL1, located on the X chromosome, encodes three protein isoforms that are particularly abundant in skeletal and cardiac muscle tissue. The gene's full name, four and a half LIM domains 1, reflects the characteristic structural motifs found in the encoded proteins. These proteins maintain the mechanical and structural integrity of muscle cells, coordinating assembly of the contractile machinery and participating in cellular signalling networks.
Pathogenic variants in FHL1 cause a clinically heterogeneous group of inherited muscle conditions known as FHL1-related myopathies or FHL1opathies. Because the gene resides on the X chromosome, these conditions predominantly affect males, though female carriers may occasionally exhibit milder symptoms. The spectrum ranges from progressive muscular dystrophy with cardiac involvement to conditions affecting specific muscle groups.
What the gene does
The FHL1 protein isoforms serve multiple functions within muscle cells, with the full-length FHL1A isoform being the most extensively characterised. FHL1A interacts with numerous other proteins to facilitate sarcomere assembly, the fundamental contractile units that enable muscle contraction. These protein-protein interactions also regulate intracellular signalling pathways that influence muscle cell growth, size determination, and structural maintenance.
The shorter FHL1B isoform demonstrates dynamic localisation, shuttling between the cytoplasm and nucleus whilst also associating with the nuclear envelope, the double-membrane structure surrounding the nucleus. The precise functional significance of this nuclear envelope association is not yet understood. Both FHL1B and FHL1C are thought to contribute to normal skeletal and cardiac muscle architecture and function, though their specific molecular roles are less well defined than those of FHL1A.
Collectively, the FHL1 isoforms appear to act as scaffolding proteins that organise protein complexes essential for muscle cell integrity. Their involvement in both structural support and signal transduction positions them as key regulators of muscle adaptation to mechanical stress.
Video: Genetics 101
Chromosome location
FHL1 is located at chromosomal position Xq26.3 on the long arm of the X chromosome. This X-linked location accounts for the inheritance pattern observed in FHL1-related conditions, where males typically express the full clinical phenotype whilst females may be asymptomatic carriers or exhibit milder manifestations due to X-inactivation patterns. The gene encodes a relatively compact protein of 323 amino acids.
Protein structure
The FHL1 protein is organised around characteristic LIM domain architecture, featuring multiple zinc-binding modules. The structure includes an N-terminal C4-type zinc finger spanning amino acids 7-31, followed by three sequential LIM zinc-binding domains: LIM zinc-binding domain 1 (amino acids 40-92), LIM zinc-binding domain 2 (amino acids 101-153), and LIM zinc-binding domain 3 (amino acids 162-212). These LIM domains are double zinc-finger motifs that mediate protein-protein interactions, enabling FHL1 to serve as a molecular scaffold. The modular arrangement of these domains allows the protein to simultaneously engage multiple binding partners, coordinating complex assembly and signalling events within muscle cells.
Key variants
Pathogenic variants in FHL1 encompass a range of molecular changes including missense variants, small deletions, and insertions. Different variant types and locations within the gene appear to correlate with distinct clinical presentations within the FHL1opathy spectrum. The X-linked inheritance means that hemizygous males carrying pathogenic variants typically manifest disease, whilst heterozygous females may show variable expression depending on X-inactivation patterns.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.288del | p.Phe96fs | Pathogenic | ★★☆☆ | X-linked myopathy with postural muscle atrophy |
c.406_409dup | p.Val137fs | Pathogenic | ★★☆☆ | X-linked myopathy with postural muscle atrophy |
c.496T>C | p.Cys166Arg | Pathogenic/Likely pathogenic | ★★☆☆ | X-linked myopathy with postural muscle atrophy |
c.576C>G | p.Tyr192Ter | Pathogenic/Likely pathogenic | ★★☆☆ | X-linked myopathy with postural muscle atrophy |
c.590G>A | p.Trp197Ter | Pathogenic | ★★☆☆ | Uruguay Faciocardiomusculoskeletal syndrome |
c.613_614del | p.Val205fs | Pathogenic | ★★☆☆ | X-linked myopathy with postural muscle atrophy |
c.640C>T | p.Gln214Ter | Pathogenic | ★★☆☆ | X-linked myopathy with postural muscle atrophy |
c.664C>T | p.Gln222Ter | Pathogenic | ★★☆☆ | X-linked myopathy with postural muscle atrophy |
c.671dup | p.Tyr224Ter | Pathogenic | ★★☆☆ | X-linked myopathy with postural muscle atrophy |
c.841_844dup | p.Phe282fs | Pathogenic/Likely pathogenic | ★★☆☆ | X-linked myopathy with postural muscle atrophy |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
FHL1-related myopathies represent a clinically diverse group of muscle disorders sharing FHL1 as their genetic basis. These include Emery-Dreifuss muscular dystrophy, which affects skeletal and cardiac muscle and is characterised by joint contractures that restrict movement, alongside progressive muscle weakness and wasting. Additional phenotypes within the FHL1opathy spectrum include reducing body myopathy, X-linked scapuloperoneal myopathy, X-linked myopathy with postural muscle atrophy, and rigid spine syndrome. Common features across these conditions include skeletal muscle involvement with varying distribution patterns and, in many cases, cardiac complications requiring ongoing monitoring.
No disease links recorded for this gene in our reference set.
UK clinical status
Within the NHS Genomic Medicine Service, FHL1 appears on multiple clinical panels with green (high evidence) classification. These include the Congenital muscular dystrophy panel (R79), Hypertrophic cardiomyopathy panel (R131), and the Limb girdle muscular dystrophies, myofibrillar myopathies and distal myopathies panel (R82). The gene is also listed on the Paediatric or syndromic cardiomyopathy panel (R135), the Distal myopathies panel, and the Developmental Disorders Gene-to-Phenotype database (DDG2P). This broad panel representation reflects the phenotypic heterogeneity of FHL1-related conditions and the importance of considering this gene in differential diagnosis across multiple muscle and cardiac presentations.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
Why are FHL1-related conditions more common in males?
FHL1 is located on the X chromosome, meaning males have only one copy whilst females have two. Males with a pathogenic FHL1 variant will typically develop disease because they lack a second, functional copy to compensate. Females may be unaffected carriers or show milder symptoms depending on which X chromosome is active in their muscle cells.
What is the difference between the various FHL1-related myopathies?
The FHL1opathy spectrum encompasses several clinically distinct conditions that share FHL1 as their genetic cause but differ in which muscle groups are affected, age of onset, and presence of cardiac involvement. Specific variant location and type within FHL1 appear to influence which phenotype develops, though some overlap exists between these traditionally separate diagnoses.
Do all FHL1 variants cause heart problems?
Not all FHL1-related conditions involve cardiac complications, though several phenotypes within the spectrum do carry risk of cardiomyopathy or cardiac conduction abnormalities. The specific FHL1 variant and resulting clinical diagnosis influence cardiac risk, making individualised cardiac monitoring important for affected individuals.
References
- Ziat E, Mamchaoui K, Beuvin M. FHL1B Interacts with Lamin A/C and Emerin at the Nuclear Lamina and is Misregulated in Emery-Dreifuss Muscular Dystrophy. Journal of neuromuscular diseases. 2016. PMID: 27911330
- Bertrand AT, Bönnemann CG, Bonne G. 199th ENMC international workshop: FHL1 related myopathies, June 7-9, 2013, Naarden, The Netherlands. Neuromuscular disorders : NMD. 2014. PMID: 24613424
- Wilding BR, McGrath MJ, Bonne G. FHL1 mutants that cause clinically distinct human myopathies form protein aggregates and impair myoblast differentiation. Journal of cell science. 2014. PMID: 24634512
- Cowling BS, Cottle DL, Wilding BR. Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Neuromuscular disorders : NMD. 2011. PMID: 21310615
- Schessl J, Feldkirchner S, Kubny C. Reducing body myopathy and other FHL1-related muscular disorders. Seminars in pediatric neurology. 2011. PMID: 22172421
- Schessl J, Taratuto AL, Sewry C. Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1. Brain : a journal of neurology. 2009. PMID: 19181672
- Gueneau L, Bertrand AT, Jais JP. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. American journal of human genetics. 2009. PMID: 19716112
- Windpassinger C, Schoser B, Straub V. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. American journal of human genetics. 2008. PMID: 18179888
- Quinzii CM, Vu TH, Min KC. X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1. American journal of human genetics. 2008. PMID: 18179901
- Shalaby S, Hayashi YK, Goto K. Rigid spine syndrome caused by a novel mutation in four-and-a-half LIM domain 1 gene (FHL1). Neuromuscular disorders : NMD. 2008. PMID: 18952429